Can the Restriction Point be Targeted Therapeutically?
Given its critical role in cell cycle control, the restriction point is a potential target for therapeutic interventions. Drugs that can modulate the activity of CDKs, such as CDK inhibitors, are being studied for their ability to halt the proliferation of cancer cells. By restoring proper checkpoint function, these therapies aim to prevent the uncontrolled growth characteristic of cancer.
